ACP
Altitude Crest Partners Portfolio holdings
AUM
$234M
1 Year Est. Return
–
AUM
$149M
AUM Growth
–
Holding
12
Top Buys
| 1 | +$32.6M | |
| 2 | +$30.5M | |
| 3 | +$28.1M | |
| 4 |
argenx
ARGX
|
+$11.2M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$11M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Legend Biotech
LEGN
$6.04B
| $32.6M | 21.82% |
+541,816
|
|
||
2
BridgeBio Pharma
BBIO
$10.5B
| $30.5M | 20.38% |
+754,560
|
|
||
3
Danaher
DHR
$151B
| $28.1M | 18.82% |
+121,600
|
|
||
|
4
argenx
ARGX
$52.4B
| $11.2M | 7.51% |
+29,500
|
|
||
|
5
BioMarin Pharmaceuticals
BMRN
$10.2B
| $11M | 7.36% |
+114,042
|
|
||
6
Apellis Pharmaceuticals
APLS
$3.41B
| $9.11M | 6.1% |
+152,200
|
|
||
7
Roivant Sciences
ROIV
$12.3B
| $9.07M | 6.07% |
+808,061
|
|
||
8
Kiniksa Pharmaceuticals
KNSA
$2.91B
| $8M | 5.35% |
+456,041
|
|
||
9
Exact Sciences
EXAS
$11.9B
| $7.33M | 4.91% |
+99,130
|
|
||
10
Aligos Therapeutics
ALGS
$72.6M
| $1.89M | 1.26% |
+113,787
|
|
||
|
AMAM
11
DELISTED
Ambrx Biopharma Inc
AMAM
| $614K | 0.41% |
+43,100
|
|
||
12
Surrozen Inc Warrant
SRZNW
$36.6K
| $7.69K | 0.01% |
+384,573
|
|